Zomedica to Present at LD Micro Main Event XV Conference

ANN ARBOR, MI / ACCESSWIRE / October 18, 2022 / Zomedica Corp. (the “Company”) (NYSE American:ZOM) announced today that Larry Heaton, Zomedica’s Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the LD Micro Main Event XV Conference on October 25, 2022 at the Luxe Sunset Boulevard Hotelin Bel Air, California.

To access the live webcast for the presentation on October 25th at 10am PDT/1:00 pm EDT, please visit https://me22.mysequire.com/ to access the Track 2 presentation; or check Zomedica’s website after the conference at https://investors.zomedica.com/events-presentations for an archived copy.

To register for the conference and participate in 1 on 1 meetings please visit LD Micro Main Event XV – Oct 25th to 27th, 2022 (meetmax.com)

About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica’s mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

Investor Relations Contact:
PCG Advisory Group
Kirin Smith, President
ksmith@pcgadvisory.com
+1.646.823.8656

SOURCE: Zomedica Corp.

About The Wall Street Analyzer 1208 Articles
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.

Be the first to comment

Leave a Reply